FIELD: medicine.
SUBSTANCE: invention is applied for α2-antiplasmin (α2-AP) level normalisation for metabolic syndrome (MS) patients. Method involves long-term individual hypocaloric diet, rated physical exercise and administration of medicine - 30 mg of pioglitasone once per day and 80 mg of valsartan 1 time at one and the same day time - for α2-AP level normalization for MS patients.
EFFECT: α2-AP level disorder normalisation for MS patients in three months time to a level of healthy people.
1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF THROMBIN TIME NORMALISATION FOR METABOLIC SYNDROME | 2007 |
|
RU2349318C1 |
| METHOD OF QUICK ENDOTHELIOCYTEMIA NORMALISATION ASSOCIATED WITH METABOLIC SYNDROME | 2007 |
|
RU2345767C1 |
| METHOD OF OPTIMISATION OF PROTEIN C ACTIVITY AT METABOLIC SYNDROME | 2007 |
|
RU2342934C1 |
| METHOD OF THROMBOPLASTIN FORMATION FOR PATIENTS WITH METABOLIC SYNDROME | 2007 |
|
RU2332205C1 |
| METHOD FOR ENHANCEMENT OF THROMBOCYTE ANTIOXIDANT PROOFNESS IN ARTERIAL HYPERTENSION CASES WITH METABOLIC SYNDROME | 2007 |
|
RU2331416C1 |
| METHOD OF VASCULAR WALL FUNCTIONAL WEAKENING CORRECTION ASSOCIATED WITH METABOLIC SYNDROME | 2007 |
|
RU2341262C1 |
| METHOD FOR ANGIOPATHY CORRECTION IN METABOLIC SYNDROME | 2007 |
|
RU2339375C1 |
| NORMALISATION METHOD OF LIPID CONTENT IN THROMBOCYTE MEMBRANES ASSOCIATED WITH METABOLIC SYNDROME | 2007 |
|
RU2345766C1 |
| METHOD OF NORMALISATION OF THROMBOCYTE SUSCEPTIBILITY TO AGGREGATION STIMULATION AGENTS FOR ARTERIAL HYPERTENSION PATIENTS UNDER METABOLIC SYNDROME | 2007 |
|
RU2344815C1 |
| METHOD FOR NORMALISATION OF ADENOSINE DIPHOSPHATE AND ADENOSINE TRIPHOSPHATE SECRETION BY PLATELETS IN ARTERIAL HYPERTENSION PATIENTS WITH METABOLIC SYNDROME | 2007 |
|
RU2344855C1 |
